Adaptimmune Therapeutics PLC (ADAP)
1.38
+0.09
(+6.98%)
USD |
NASDAQ |
Jul 26, 16:00
1.42
+0.04
(+2.90%)
After-Hours: 20:00
Adaptimmune Therapeutics Market Cap: 352.68M for July 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| July 25, 2024 | 329.68M |
| July 24, 2024 | 314.34M |
| July 23, 2024 | 314.34M |
| July 22, 2024 | 309.23M |
| July 19, 2024 | 299.01M |
| July 18, 2024 | 301.56M |
| July 17, 2024 | 322.01M |
| July 16, 2024 | 324.56M |
| July 15, 2024 | 318.17M |
| July 12, 2024 | 327.12M |
| July 11, 2024 | 316.90M |
| July 10, 2024 | 304.12M |
| July 09, 2024 | 306.67M |
| July 08, 2024 | 296.45M |
| July 05, 2024 | 311.79M |
| July 03, 2024 | 260.67M |
| July 02, 2024 | 268.34M |
| July 01, 2024 | 268.34M |
| June 28, 2024 | 249.15M |
| June 27, 2024 | 250.66M |
| June 26, 2024 | 212.50M |
| June 25, 2024 | 221.29M |
| June 24, 2024 | 225.05M |
| June 21, 2024 | 227.45M |
| June 20, 2024 | 223.05M |
| Date | Value |
|---|---|
| June 18, 2024 | 224.89M |
| June 17, 2024 | 239.46M |
| June 14, 2024 | 258.12M |
| June 13, 2024 | 265.78M |
| June 12, 2024 | 265.78M |
| June 11, 2024 | 265.78M |
| June 10, 2024 | 265.78M |
| June 07, 2024 | 260.67M |
| June 06, 2024 | 263.23M |
| June 05, 2024 | 270.90M |
| June 04, 2024 | 258.12M |
| June 03, 2024 | 273.45M |
| May 31, 2024 | 288.79M |
| May 30, 2024 | 258.12M |
| May 29, 2024 | 258.12M |
| May 28, 2024 | 265.78M |
| May 24, 2024 | 268.34M |
| May 23, 2024 | 258.12M |
| May 22, 2024 | 268.34M |
| May 21, 2024 | 276.01M |
| May 20, 2024 | 281.12M |
| May 17, 2024 | 283.67M |
| May 16, 2024 | 306.67M |
| May 15, 2024 | 316.90M |
| May 14, 2024 | 293.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
76.25M
Minimum
Nov 15 2019
1.750B
Maximum
Jun 04 2020
476.23M
Average
329.41M
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 10.76M |
| NuCana PLC | 8.278M |
| Mereo BioPharma Group PLC | 634.90M |
| Autolus Therapeutics PLC | 1.245B |
| TC BioPharm (Holdings) PLC | 4.451M |
Market Cap Related Metrics
| PS Ratio | 16.54 |
| Price to Book Value | 14.47 |
| Price | 1.38 |
| Earnings Yield | -47.83% |